Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Discover the complete record of transactions filed by Boilen Scott, Director. Insider active across 1 company, notably Checkpoint Therapeutics, Inc.. Cumulatively, 3 filings have been recorded. History available since 10 June 2021. The latest transaction was filed on 13 June 2023 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 of 3 declarations
Scott Boilen is a Board Member at Checkpoint Therapeutics, Inc. He contributes to the strategic direction of the company, bringing his expertise in biotechnology and product development. His role is crucial in guiding decisions and operations.